294 related articles for article (PubMed ID: 31131542)
21. Monocyte activation, HIV, and cognitive performance in East Africa.
Muñoz-Nevárez LA; Imp BM; Eller MA; Kiweewa F; Maswai J; Polyak C; Olwenyi OA; Allen IE; Rono E; Milanini B; Kibuuka H; Ake JA; Eller LA; Valcour VG
J Neurovirol; 2020 Feb; 26(1):52-59. PubMed ID: 31468471
[TBL] [Abstract][Full Text] [Related]
22. Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients.
Noel N; Boufassa F; Lécuroux C; Saez-Cirion A; Bourgeois C; Dunyach-Remy C; Goujard C; Rouzioux C; Meyer L; Pancino G; Venet A; Lambotte O;
AIDS; 2014 Feb; 28(4):467-76. PubMed ID: 24378753
[TBL] [Abstract][Full Text] [Related]
23. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
[TBL] [Abstract][Full Text] [Related]
24. CD1d-Restricted Natural Killer T Cells Are Preserved in Indian Long-Term Nonprogressors.
Singh D; Ghate M; Godbole S; Kulkarni S; Thakar M
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e104-e112. PubMed ID: 28650939
[TBL] [Abstract][Full Text] [Related]
25. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women.
Fitch KV; Srinivasa S; Abbara S; Burdo TH; Williams KC; Eneh P; Lo J; Grinspoon SK
J Infect Dis; 2013 Dec; 208(11):1737-46. PubMed ID: 24041790
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
Fourman LT; Czerwonka N; Shaikh SD; Stanley TL; Burdo TH; Williams KC; Fitch KV; Lo J; Grinspoon SK
AIDS; 2018 Apr; 32(7):927-932. PubMed ID: 29424780
[TBL] [Abstract][Full Text] [Related]
28. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients.
Hønge BL; Andersen MN; Jespersen S; Medina C; Correira FG; Jakobsen MR; Laursen A; Erikstrup C; Møller HJ; Wejse C;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):254-8. PubMed ID: 26825178
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with conversion of long-term non-progressors to progressors: a prospective study of HIV perinatally infected paediatric survivors.
Radhakrishna M; Durga K; Rao RK; Reddy DM; Kondapi AK
Indian J Med Res; 2013 Sep; 138(3):322-8. PubMed ID: 24135176
[TBL] [Abstract][Full Text] [Related]
30. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
31. Plasma proteomics analysis of Chinese HIV-1 infected individuals focusing on the immune and inflammatory factors afford insight into the viral control mechanism.
Ni W; Ren L; Liao L; Li D; Luo Z; Zhu M; Liu Y; Xing H; Wang Z; Shao Y
Front Immunol; 2024; 15():1378048. PubMed ID: 38799426
[TBL] [Abstract][Full Text] [Related]
32. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
[TBL] [Abstract][Full Text] [Related]
33. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.
Williams JC; Zhang X; Karki M; Chi YY; Wallet SM; Rudy BJ; Nichols SL; Goodenow MM; Sleasman JW
J Leukoc Biol; 2018 Apr; 103(4):671-680. PubMed ID: 29377283
[TBL] [Abstract][Full Text] [Related]
35. Conventional Dendritic Cells and Slan
Iannetta M; Isnard S; Manuzak J; Guillerme JB; Notin M; Bailly K; Andrieu M; Amraoui S; Vimeux L; Figueiredo S; Charmeteau-de Muylder B; Vaton L; Hatton EX; Samri A; Autran B; Thiébaut R; Chaghil N; Glohi D; Charpentier C; Descamps D; Brun-Vézinet F; Matheron S; Cheynier R; Hosmalin A
Front Immunol; 2020; 11():1658. PubMed ID: 32903610
[TBL] [Abstract][Full Text] [Related]
36. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
[TBL] [Abstract][Full Text] [Related]
37. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection.
Liang H; Duan Z; Li D; Li D; Wang Z; Ren L; Shen T; Shao Y
Cell Mol Immunol; 2015 Jul; 12(4):435-43. PubMed ID: 25109683
[TBL] [Abstract][Full Text] [Related]
38. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
[TBL] [Abstract][Full Text] [Related]
39. High levels of anti-Nef antibodies may prevent AIDS disease progression in vertically HIV-1-infected infants.
Corró G; Crudeli CM; Rocco CA; Marino SA; Sen L
J Int AIDS Soc; 2014; 17(1):18790. PubMed ID: 24560340
[TBL] [Abstract][Full Text] [Related]
40. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
